Table 2.
EBV-DNA | T classificationa | N classificationa | GTV | ||
---|---|---|---|---|---|
Median (range) | γ | γ | γ | γ | |
Neutrophil, % | 63.1 (31.7–86.1) | 0.09 | 0.10 | −0.04 | −0.07 |
Lymphocyte, % | 28.4 (10.0–51.3) | −0.27** | 0.11 | 0.03 | −0.01 |
Monocyte, % | 5.6 (0.8–11.7) | 0.28** | 0.10 | 0.01 | 0.18* |
Platelet, 109/l | 236 (112–498) | 0.20* | 0.07 | 0.07 | 0.27** |
N/L ratio | 2.21 (0.62–8.61) | 0.14 | −0.08 | −0.04 | −0.02 |
L/M ratio | 5.04 (1.25–21.25) | −0.29** | −0.05 | 0.05 | −0.17* |
P/L ratio | 8.43 (3.14–37.60) | 0.32** | −0.01 | 0.01 | 0.18* |
EBV-DNA, copies/ml | 106 (0–94,920) | – | 0.04 | 0.31** | 0.39** |
N/L ratio neutrophil to lymphocyte ratio, L/M ratio lymphocyte-to-monocyte ratio, P/L ratio platelet to lymphocyte ratio, EBV Epstein-Barr virus, GTV gross tumor volume
*p < 0.01, ** p < 0.001, γ: correlation coefficient
aAccording to the AJCC 7th staging system